Y-29794 Tosylate
CAS No. 143984-17-2
Y-29794 Tosylate ( Y 29794 | Y-29794 | Y29794 | Y29794 tosylate | Y-29794 tosylate | Y 29794 tosylate )
产品货号. M28022 CAS No. 143984-17-2
Y-29794 Tosylate 是一种具有口服活性、有效且特异性的非肽脯氨酰内肽酶 (PPCE) 抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥551 | 有现货 |
|
| 5MG | ¥786 | 有现货 |
|
| 10MG | ¥1126 | 有现货 |
|
| 25MG | ¥1855 | 有现货 |
|
| 50MG | ¥3337 | 有现货 |
|
| 100MG | ¥4965 | 有现货 |
|
| 500MG | ¥10692 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Y-29794 Tosylate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Y-29794 Tosylate 是一种具有口服活性、有效且特异性的非肽脯氨酰内肽酶 (PPCE) 抑制剂。
-
产品描述Y-29794 Tosylate is an orally active, effective, and specific non-peptide-prolyl endopeptidase (PPCE) inhibitor.(In Vitro):Y-29794 Tosylate could penetrate into brain to exhibit dose-dependent and long-lasting inhibition.(In Vivo):Y-29794 Tosylate selectively and competitively inhibited rat brain PPCE in a reversible manner. Y-29794 Tosylate was found to potentiate the effect of TRH on the release of ACh in the rat hippocampus.
-
体外实验——
-
体内实验——
-
同义词Y 29794 | Y-29794 | Y29794 | Y29794 tosylate | Y-29794 tosylate | Y 29794 tosylate
-
通路Others
-
靶点Other Targets
-
受体RSK1|RSK2|RSK3|CDK5/p35|DRAK1|FLT3|Pim1|SGK
-
研究领域——
-
适应症——
化学信息
-
CAS Number143984-17-2
-
分子量590.86
-
分子式C30H42N2O4S3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCc1ccc(cc1)S(O)(=O)=O.CC(C)c1ccc(C(=O)c2cccs2)c(SCCCCCCCCN(C)C)n1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Park YS, et al. EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors. Mol Cell Biochem. 2012 Nov;370(1-2):191-8.
产品手册
关联产品
-
NSI-189
NSI-189 是一种源自烟酰胺和吡嗪的促智和神经源性研究化学品。
-
Deschloroclozapine
Des氯氯氮平是氯氮平的代谢产物,是一种高效毒蕈碱 DREADDs 激动剂。
-
Cefuroxime
Cefuroxime 是一种具有口服活性的第二代头孢菌素抗生素 (antibiotic),增加了对 β-内酰胺酶 (β-lactamase) 的稳定性。Cefuroxime 具有广谱的抑制活性,对革兰氏阳性菌和革兰氏阴性菌都有效。
021-51111890
购物车()
sales@molnova.cn

